Secondary Hypogonadotrophic hypogonadism

Also known as: Secondary Hypogonadism / Hypopituitarism / Hypogonadotropic Hypogonadism / Hypogonadotropic hypogonadism (disorder) / Hypogonadotrophic hypogonadism

Drug	Drug Name	Drug Description
DB00097	Choriogonadotropin alfa	A recombinant form of human chorionic gonadotropin used to treat female infertility by inducing ovulation.
DB09126	Chorionic Gonadotropin (Human)	A naturally-occurring hormone produced during human placenta used for the treatment of prepubertal cryptorchidism and hypogonadotropic hypogonadism in selected males, and induction of pregnancy in selected infertile women.

Drug	Drug Name	Target	Type
DB00097	Choriogonadotropin alfa	Follicle-stimulating hormone receptor	target
DB00097	Choriogonadotropin alfa	Lutropin-choriogonadotropic hormone receptor	target
DB09126	Chorionic Gonadotropin (Human)	Lutropin-choriogonadotropic hormone receptor	target

Drug	Drug Name	Phase	Status	Count
DB00882	Clomifene	1	Completed	3
DB06735	Enclomiphene	1	Completed	2
DB00882	Clomifene	2	Completed	4
DB06735	Enclomiphene	2	Completed	4
DB06640	Fispemifene	2	Unknown Status	1
DB00624	Testosterone	2	Completed	3
DB13946	Testosterone undecanoate	2	Completed	1
DB00882	Clomifene	3	Completed	8
DB06735	Enclomiphene	3	Completed	6
DB00624	Testosterone	3	Completed	3
DB13946	Testosterone undecanoate	3	Completed	1
DB00624	Testosterone	4	Completed	1